These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Acetylcarnitine Is Associated With Cardiovascular Disease Risk in Type 2 Diabetes Mellitus. Zhao S, Liu ML, Huang B, Zhao FR, Li Y, Cui XT, Lin R. Front Endocrinol (Lausanne); 2021 Sep 30; 12():806819. PubMed ID: 34970228 [Abstract] [Full Text] [Related]
9. Fluorophores advanced glycation end products (AGEs)-to-NADH ratio is predictor for diabetic chronic kidney and cardiovascular disease. Ciobanu DM, Olar LE, Stefan R, Veresiu IA, Bala CG, Mircea PA, Roman G. J Diabetes Complications; 2015 Sep 30; 29(7):893-7. PubMed ID: 26169772 [Abstract] [Full Text] [Related]
10. [Cardiovascular disease in patients with type 1 and type 2 diabetes in Spain]. Ortega E, Amor AJ, Rojo-Martínez G, Castell C, Giménez M, Conget I. Med Clin (Barc); 2015 Sep 21; 145(6):233-8. PubMed ID: 25561182 [Abstract] [Full Text] [Related]
12. Fasting serum lipid and dehydroepiandrosterone sulfate as important metabolites for detecting isolated postchallenge diabetes: serum metabolomics via ultra-high-performance LC-MS. Liu L, Wang M, Yang X, Bi M, Na L, Niu Y, Li Y, Sun C. Clin Chem; 2013 Sep 21; 59(9):1338-48. PubMed ID: 23620415 [Abstract] [Full Text] [Related]
13. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry. Long J, Liu L, Jia Q, Yang Z, Sun Z, Yan C, Yan D. Rapid Commun Mass Spectrom; 2020 Jun 30; 34(12):e8779. PubMed ID: 32159245 [Abstract] [Full Text] [Related]
14. Plasma metabolite profiles associated with the World Cancer Research Fund/American Institute for Cancer Research lifestyle score and future risk of cardiovascular disease and type 2 diabetes. Rios S, García-Gavilán JF, Babio N, Paz-Graniel I, Ruiz-Canela M, Liang L, Clish CB, Toledo E, Corella D, Estruch R, Ros E, Fitó M, Arós F, Fiol M, Guasch-Ferré M, Santos-Lozano JM, Li J, Razquin C, Martínez-González MÁ, Hu FB, Salas-Salvadó J. Cardiovasc Diabetol; 2023 Sep 16; 22(1):252. PubMed ID: 37716984 [Abstract] [Full Text] [Related]
16. Metabolomic biomarkers of impaired glucose tolerance and type 2 diabetes mellitus with a potential for risk stratification in women with polycystic ovary syndrome. Galazis N, Iacovou C, Haoula Z, Atiomo W. Eur J Obstet Gynecol Reprod Biol; 2012 Feb 16; 160(2):121-30. PubMed ID: 22136882 [Abstract] [Full Text] [Related]
18. Simultaneous quantification of cardiovascular disease related metabolic risk factors using liquid chromatography tandem mass spectrometry in human serum. Wang M, Yang R, Dong J, Zhang T, Wang S, Zhou W, Li H, Zhao H, Zhang L, Wang S, Zhang C, Chen W. J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan 15; 1009-1010():144-51. PubMed ID: 26735710 [Abstract] [Full Text] [Related]
20. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome? van der Velde M, Bello AK, Brantsma AH, El Nahas M, Bakker SJ, de Jong PE, Gansevoort RT. Nephrol Dial Transplant; 2012 Jun 15; 27(6):2275-83. PubMed ID: 22231032 [Abstract] [Full Text] [Related] Page: [Next] [New Search]